DC Coupled Amplifier Waveform Generation for Neuromuscular Therapy
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing electrical neuromuscular stimulation devices are limited by their ability to generate waveforms within a narrow frequency range, which restricts their therapeutic effectiveness in treating a variety of ailments.
Innovation Solution
The use of novel electronic circuitry employing DC coupled amplifiers to produce composite waveforms ranging from 1 Hz to 50 KHz, allowing for customized waveforms tailored to individual patients and treatment areas through frequency sweeps and feedback mechanisms.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Adaptability or versatility
If output transformers are used to generate waveforms, then device complexity is reduced, but the frequency range is limited to a narrow range
Solution Approach 1:
The patent replaces the mechanical transformer-based waveform generation system with an electronic circuit system using DC coupled amplifiers. This substitution enables the generation of composite waveforms across a broad frequency range (1 Hz to 50 KHz) without the frequency limitations inherent in transformer designs, thereby resolving the contradiction between frequency range adaptability and device complexity.
Solution Approach 2:
The patent employs DC coupled amplifiers that can dynamically adjust and generate composite waveforms across a wide frequency spectrum (1 Hz to 50 KHz). This parameter change capability allows the system to adapt to different treatment requirements and tissue types, achieving broad frequency range coverage while maintaining manageable device complexity through electronic control.
2Reliability
If generic waveforms are used for treatment, then ease of operation is improved, but therapeutic effectiveness is reduced
Solution Approach 1:
The patent incorporates frequency sweep and feedback mechanisms that enable the system to automatically identify optimal waveforms for specific patients and treatment areas. This self-service capability allows the device to perform waveform customization autonomously, maintaining ease of operation while significantly improving therapeutic effectiveness through personalized treatment parameters.
Solution Approach 2:
The patent implements feedback mechanisms that monitor tissue response and adjust waveforms accordingly. This feedback loop enables the system to identify optimal treatment parameters automatically, ensuring therapeutic effectiveness is maximized for each patient while requiring minimal manual intervention, thus resolving the contradiction between reliability and ease of operation.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables more effective neuromuscular therapy by identifying optimal waveforms that minimize tissue impedance, leading to enhanced blood and oxygen circulation, pain relief, and improved muscle function.
Implementation Method 1
employing DC coupled amplifiers to produce composite waveforms in the rage of 1 Hz to 50 KHz
Implementation Method 2
stimulating the nervous system to contract the muscles using electrical pulses generally similar to the electrical impulses from the human's brain
Implementation Method 3
the human body responds to electrical pulses from electrical stimulation units increasing the volume blood and oxygen circulated to the area being treated
Data Source
AI summary
A method of treating a patient includes an initial step of applying an initial scanning waveform to a patient's skin at a first area associated with a site of neurological disruption and monitoring to determine a first neurologically disrupted site. Upon locating at least one first neurologically disrupted site, the method can include scanning for at least a second neurologically disrupted site. Then the method may include conducting a frequency sweep to determine desired treatment frequencies, locating auxiliary treatment points, and treating the first and second neurologically disrupted sites concurrent with the auxiliary treatment points.


